ArticleJournal of personalized medicine2021

Prognostic Value of Histone Modifying Enzyme EZH2 in RCHOP-Treated Diffuse Large B-Cell Lymphoma and High Grade B-Cell Lymphoma.

Sara Petronilho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.